The N676D and G697R Mutations in the Kinase Domain of FLT3 Confer Resistance to the Inhibitor AC220

Haematologica - Italy
doi 10.3324/haematol.2012.069781
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

FLT3 D835 Mutations Confer Differential Resistance to Type II FLT3 Inhibitors

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations

PLoS ONE
Multidisciplinary
2014English

Overcoming AC220 Resistance of FLT3-ITD by SAR302503

Blood Cancer Journal
OncologyHematology
2013English

Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924

Cancer Cell
Cancer ResearchOncologyCell Biology
2012English

Mutations in the Arabidopsis Homoserine Kinase Gene DMR1 Confer Enhanced Resistance to Fusarium Culmorum and F. Graminearum

BMC Plant Biology
Plant Science
2014English

Mutations in Ribosomal Protein L10e Confer Resistance to the Fungal-Specific Eukaryotic Elongation Factor 2 Inhibitor Sordarin

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Do Mutations of the Pendred Syndrome Gene, SLC26A4, Confer Resistance to Asthma and Hypertension?

Journal of Medical Genetics
Genetics
2009English

Mutations in the Reduced Folate Carrier Gene Which Confer Dominant Resistance to 5,10-Dideazatetrahydrofolate

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy